Oyster Point Pharma logo
Oyster Point Pharma OYST
$ 11.17 0.0%

Quarterly report 2022-Q3
added 11-10-2022

report update icon

Oyster Point Pharma Financial Statements 2011-2024 | OYST

Annual Financial Statements Oyster Point Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

286 M 86.1 M 146 M - - - - - - - -

Shares

26 M 4.59 M 4.59 M - - - - - - - -

Historical Prices

12 18.8 31.5 - - - - - - - -

Net Income

-101 M -70.5 M -45.7 M -16.5 M -6.6 M - - - - - -

Revenue

24.5 M - - - - - - - - - -

Cost of Revenue

1.52 M - - - - - - - - - -

Gross Profit

- - - - - - - - - - -

Operating Income

-96.7 M -71 M -47.3 M -16.7 M - - - - - - -

Interest Expense

3.73 M - - - - - - - - - -

EBITDA

-96.5 M -70.5 M -47.3 M -16.5 M -5.64 M - - - - - -

Operating Expenses

120 M 71 M 47.3 M - - - - - - - -

General and Administrative Expenses

40.8 M 31.2 M 13.7 M 2.98 M 2.05 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Oyster Point Pharma

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 26.8 M 26.7 M 26.6 M 26.6 M 26 M 26 M 25.9 M 25.9 M 25.8 M 23.4 M 21.4 M 14 M 1.42 M 1.41 M 1.41 M 1.41 M 1.41 M 1.41 M 1.41 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- -36.7 M -49.9 M -47.9 M - -17.7 M -22 M -18.9 M -22.2 M -16.3 M -15.5 M -16.5 M -19.7 M -11.5 M -10.7 M -3.76 M -4.01 M -6.63 M -2.93 M -2.93 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- 5.59 M 4.69 M 2.7 M - 17.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- 1.35 M 1.31 M 336 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- -33.9 M -43.4 M -42.2 M - -16.8 M -22 M -18.9 M -22.2 M -16.3 M -15.5 M -16.9 M -20.2 M -11.9 M -11.2 M -4.01 M -4.05 M -6.69 M -3 M -3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- 3.5 M 3.16 M 3.07 M - 1.12 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -33.7 M -43.2 M -42.1 M - -16.7 M -22 M -18.9 M -22.2 M -16.3 M -15.5 M -16.9 M -20.2 M -11.9 M -11.2 M -4.01 M -4.05 M -6.69 M -3 M -3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- 38.2 M 46.8 M 44.6 M - 34.7 M 22 M 18.9 M 22.2 M 16.3 M 15.5 M 16.9 M 20.2 M 11.9 M 11.2 M 4.01 M 4.05 M 6.69 M 3 M 3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- 12.1 M 14 M 12.9 M - 10.3 M 9.09 M 8.52 M 10.5 M 8.11 M 6.94 M 5.59 M 5.13 M 3.81 M 3.13 M 1.6 M 704 K 916 K 735 K 626 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency